Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulator

被引:12
作者
Hayashi, M
Satou, E
Ueki, R
Yano, M
Miyano-Kurosaki, N
Fujii, M
Takaku, H
机构
[1] Chiba Inst Technol, Fac Engn, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan
[2] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 2750016, Japan
[3] Kinki Univ, Kyushu Sch Engn, Dept Chem, Iizuka, Fukuoka 8208555, Japan
基金
日本学术振兴会;
关键词
oligonucleotides; antigen-conjugated oligonucleotides; immunostimulatory sequences; influenza virus; hemagglutinin Th1;
D O I
10.1016/j.bbrc.2005.01.116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oligodeoxynucleotides (ODN) containing CpG motifs (CpG) act as modulators that bias the immune response towards a Th1-dominant phenotype. To investigate this effect further, we examined the protective effects of a covalently linked conjugate between CpG-ODN and HA-2kd antigen in mice infected with influenza A virus. The conjugated form of CpG-ODN and HA-2kd was more efficient in regulating influenza A virus than the unconjugated mixture of CpG-ODN and HA-2kd. The antigen-conjugated CpG-ODN induced an immune response with a Th1-dominant cytokine pattern characterized by the secretion of high levels of HA-2kd-specific interferon-gamma and IgG2a (Th1), which were only slightly induced by HA-2kd alone. These findings support the use of CpG-ODN-Ag conjugates as novel Ag-specific immunomodulators and suggest that CpG-ODN-HA-2kd might be a promising immune therapy for patients with influenza virus. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 34 条
[1]   Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice [J].
Abe, T ;
Takahashi, H ;
Hamazaki, H ;
Miyano-Kurosaki, N ;
Matsuura, Y ;
Takaku, H .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1133-1139
[2]   Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs [J].
Ballas, ZK ;
Krieg, AM ;
Warren, T ;
Rasmussen, W ;
Davis, HL ;
Waldschmidt, M ;
Weiner, GJ .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :4878-4886
[3]   Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients [J].
Blazar, BR ;
Krieg, AM ;
Taylor, PA .
BLOOD, 2001, 98 (04) :1217-1225
[4]   Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism [J].
Cho, HJ ;
Takabayashi, K ;
Cheng, PM ;
Nguyen, MD ;
Corr, M ;
Tuck, S ;
Raz, E .
NATURE BIOTECHNOLOGY, 2000, 18 (05) :509-514
[5]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631
[6]  
DAVIS HL, 2000, 3 ANN C VACC RES S, V25, P47
[7]   An immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response [J].
Dong, L ;
Mori, I ;
Hossain, MJ ;
Liu, BX ;
Kimura, Y .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :1623-1628
[8]   Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo [J].
Hartmann, G ;
Weeratna, RD ;
Ballas, ZK ;
Payette, P ;
Blackwell, S ;
Suparto, I ;
Rasmussen, WL ;
Waldschmidt, M ;
Sajuthi, D ;
Purcell, RH ;
Davis, HL ;
Krieg, AM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (03) :1617-1624
[9]   CpG DNA as a Th1 trigger [J].
Heeg, K ;
Zimmermann, S .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2000, 121 (02) :87-97
[10]   DNA-based immunotherapeutics for the treatment of allergic disease [J].
Horner, AA ;
Van Uden, JH ;
Zubeldia, JM ;
Broide, D ;
Raz, E .
IMMUNOLOGICAL REVIEWS, 2001, 179 :102-118